SIMABS
Agoralaan, Abis Abis /
3590 Diepenbeek
BE
SIMABS
Foundation date
22AUG2019
Sector
#Biotechnology / R&D ServicesSubsector
Therapeutic areas
SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.
Upcoming events
All events-
2309 '20
Talent accelerator programme for biobusiness
Event by: Helis Academy -
0210 '20
MedTech Meetup 2020
Event by: COVARTIM -
0812 '20
Translational Immunology
Event by: VIB
Latest news
More news-
Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease
Thursday August 13th 2020
Read more
-
Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study
Thursday August 13th 2020
Read more
-
BISC Global opens in Switzerland
Wednesday August 12th 2020
Read more